Jade Biosciences, Inc.
JBIO
$13.97
-$0.28-1.97%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | 20.42M | -- | -- | -- | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 113.54M | -- | -- | -- | |
| Operating Income | -113.54M | -- | -- | -- | |
| Income Before Tax | -127.35M | -- | -- | -- | |
| Income Tax Expenses | 58.00K | -- | -- | -- | |
| Earnings from Continuing Operations | -127.41 | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -127.41M | -- | -- | -- | |
| EBIT | -113.54M | -- | -- | -- | |
| EBITDA | -90.13M | -- | -- | -- | |
| EPS Basic | -10.71 | -- | -- | -- | |
| Normalized Basic EPS | -5.48 | -- | -- | -- | |
| EPS Diluted | -10.71 | -- | -- | -- | |
| Normalized Diluted EPS | -5.48 | -- | -- | -- | |
| Average Basic Shares Outstanding | 125.44M | -- | -- | -- | |
| Average Diluted Shares Outstanding | 125.44M | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |